Antimicrobial therapy of peptic ulcers

International Journal of Antimicrobial Agents

Volumn 8, Issue 3, 1997, Pages 171-178

  Miehlke, Stephan ^a   Graham, David Y ^b  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Antimicrobial therapy; H. pylori; Peptic ulcers

Indexed keywords

14 HYDROXYCLARITHROMYCIN; AMOXICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; AZITHROMYCIN; BISMUTH; BISMUTH SALICYLATE; CLARITHROMYCIN; ERYTHROMYCIN; FURAZOLIDONE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; MACROLIDE; METRONIDAZOLE; NITROIMIDAZOLE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE BISMUTH CITRATE; ROXITHROMYCIN; TETRACYCLINE; TINIDAZOLE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL INFECTION; CLINICAL TRIAL; DRUG EFFICACY; DUODENUM ULCER; HELICOBACTER PYLORI; HUMAN; META ANALYSIS; MINIMUM INHIBITORY CONCENTRATION; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PRIORITY JOURNAL; STOMACH ULCER; TREATMENT FAILURE;

EID: 0030905374     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(97)00368-3     Document Type: Article

References (91)

1. Graham DY. Treatment of peptic ulcers caused by Helicobacter pylori. New Engl J Med 1993;329:349-350.
2. Kreiss C, Blum P, Malfertheiner P. Peptic ulcer pathogenesis. Curr Opin Gastroenterol 1995;11(suppl 1):25-31.
3. Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994;89(suppl):S116-S128.
4. Soil AH. Gastric, duodenal, and stress ulcer. In: Sleisinger M and Fordtran J (eds) Gastrointestinal Diseases, 5th edition. WB Saunders, Philadelphia, 1993, pp. 580-679.
5. Burget DW, Chiverton SG, Hunt RH. Is there an optimal degree of acid suppression for healing duodenal ulcers? Gastroenterology 1990;99:345-351.
6. Huang JQ, Sridar S, Wilkinson J, Chen Y. Hunt RH. Antibiotics accelerate healing of duodenal ulcers (DU) when combined with proton pump inhibitors (PPI) or H2-receptor antagonists (H2RA): a metaanalysis. Gastroenterology 1996;110:A137.
7. Hopkins RJ, Girardi LS, Turney EA. Relationship between Helicobacter pylori eradication and reduced duodenal and gastric ulcer recurrence. Gastroenterology 1996;11:1244-1252.
8. Armstrong D, Arnold R, Classen M, Ficher M, Goebell H, Schepp W, Blum AL, and the RUDER Study Group. RUDER - a prospective, two-year, multicenter study of risk factors for duodenal ulcer relapse during maintenance therapy with ranitidine. Dig Dis Sci 1994;39:1425-1433.
9. Dammann, HG, Walter TA. Efficacy of continous therapy for peptic ulcer in controlled clinical trials. Aliment Pharmacol Ther 1993;7(suppl 2): 17-25.
10. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994;272:65-69.
11. Breuer T, Malaty HM, Goodman K, Sudhop T, Graham DY. Treatment regimens used in Helicobacter pylori positive ulcer disease; a nationwide comparison of gastroenterologists and family practitioners in the United States of America. Gut 1996;39(suppl 2):A22.
12. Goldman AF, Zakula D, Flamm R, et al. Tight binding of clarithromycin, its 14-R-hydroxy metabolite and erythromycin to Helicobacter pylori ribosomes. Antimicrob Agents Chemother 1994;38:1496-1500.
13. Graham DY. Clarithromycin for treatment of Helicobacter pylori infection. Eur J Gastroenterol 1995;7(suppl 1):S55-S58.
14. Megraud F. H. pylori resistance to antibiotics. In: Hunt RH and Tytgat GNJ (eds): Helicobacter pylori. Basic Mechanisms to Clinical Cure. Kluwer, Dordrecht, 1994;570-583.
15. Xia HX, Keane CT, O'Morain C. Prevalence and stabilitiy of clarithromycin resistance in Helicobacter pylori: clinical implications. Am J Gastroenterol 1994;89:1391.
16. Labenz J. Helicobacter pylori - Therapie mit Omeprazol und Clarithromycin: Heutiger Stand. Leber Magen Darm 1994;24:203-209.
17. Chang K, Wyle F, Skankey J et al. Clarithromycin achieves highest gastric mucosa tissue concentrations among anti-Helicobacter pylori antibiotics. Gastroenterology 1993;104:A680.
18. Gustavson LE, Kaiser JF, Edmonds AL et al. Effect of omeprazole on concentration of clarithromycin in plasma and gastric tissue at steady state. Antimicrob Agents Chemother 1995;2078-2087.
19. Goddard AF, Logan RPH. Antimicrobial resistance and Helicobacter pylori. J Antimicrob Chemother 1996;37:639-643.
20. Ling TKW, Cheng AFB, Sung JJY, Yiu PYL, Chung SSC. An increase in Helicobacter pylori strains resistant to metronidazole: a five-year sudy. Helicobacter 1996;1:57-61.
21. Goddard AF, Jessa MF, Barrett A, et al. Effect of omeprazole on the distributions of antibiotics in gastric juice. Gastroenterology 1995;108:A102.
22. Correman MP, Krausgrill P, Hengels KJ. Local gastric and serum amoxicillin concentrations after different application forms. Antimicrob Agents Chemother 1993;37:1506-1509.
23. Adamek RJ, Wegener M, Labenz J, et al. Medium-term results of oral and intravenous omeprazole/amoxicillin Helicobacter pylori eradication therapy. Am J Gastroenterol 1994;89:39-42.
24. Chiba N, Rao, BV, Rademaker W, Hunt RH. Metaanalysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori. Am J Gastroenterot 1992;87:1716-1727.
25. Börsch GM, Graham DY. Helicobacter pylori. Pharmacology of peptic ulcer disease. In: Collen MJ and Benjamin SB (eds) Handbook of Experimental Pharmacology, Vol 99. Springer-Verlag, Berlin, 1991;107-148.
26. Peterson WL, Graham DY, Marshall B, et al. Clarithromycin as monotherapy for eradication of Helicobacter pylori: a randomized, double-blind trial. Am J Gastroenterol 1993;88:1860-1864.
27. Tytgat GNJ. Review article: treatments that impact favourable upon eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994;8:359-368.
28. Pension JC. Helicobacter pylori eradication - understandable caution but no excuse for inertia. Aliment Pharmacol Ther 1994;8:369-389.
29. Borody TJ, George LL, Brandl S, et al. Helicobacter pylori eradication with doxycycline-metronidazole-bismuth subcitrate triple therapy. Scand J Gastroenterol 1992;27:281-284.
30. Al-Assi MT, Ramirez FC, Lew GM, Graham DY. Clarithromycin, tetracycline, and bismuth: a new non-metronidazole therapy for Helicobacter pylori infection. Am J Gastroenterol 1994;89:1203-1205.
31. Hosking SW, Ling TWK, Chung SCS, et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: randomized controlled trial. Lancet 1994;343:508-510.
32. Sung JJ, Chung SCS, Ling TKW et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. New Engl J Med 1995;332:139-142.
33. Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992;102:493-496.
34. Cutler AF, Schubert TT. Patient factors affecting Helicobacter pylori eradication witn triple therapy. Am J Gastroenterol 1993;88:505-509.
35. Borody TJ, Andrews P, Shortis NP, Bae H, Brandl S. Optimal H. pylori (HP) therapy - a combination of omeprazole and triple therapy (TT). Gastroenterology 1994;106:A55.
36. Pension JG. Review article: clinical aspects of Helicobacter pylori eradication therapy in peptic ulcer disease. Aliment Pharmacol Ther 1996;10:469-486.
37. Bell GD, Powell K, Weil J, et al. Experience with omeprazole in combination with either amoxycillin or colloidal bismuth subcitrate in patients with metronidazole-resistant Helicobacter pylori. Eur J Gastroenterol Hepatol 1991;3:923-926.
38. Miehlke S, Mannes GA, Lehn N, Bayerdörffer E, Hele C, Stolte M. An increasing dose of omeprazole combined with amoxicillin cures Helicobacter pylori infection more effectively. Aliment Pharmacol Ther 1997, in press.
39. Bayerdörffer E, Miehlke S, Mannes G, Sommer.A, Höchter W, Weingart J, Heldwein W, Klann H, Simon T, Schmitt W, Bästlein E, Eimiller A, Hatz R, Lehn N, Dirschedl P, Stolte M. Double-blind trial omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology 1995;108:1412-1417.
40. Axon ATR. The role of acid inhibition in the treatment of Helicobacter pylori infection. Scand J Gastroenterol 1995;29(suppl):116-123.
41. Graham KS, Malaty H, El-Zimaity HMT, Genta RM, Cole RA, Al-Assi MT, Yousfi MM, Neil GA, Graham DY. Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori. Am J Gastroenterol 1995;90:1415-1418.
42. Logan RPH, Gummett PA, Schauffelberger HD, et al. Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut 1994;35:323-326.
43. O'Morain C, Dettmer A, Rambow A, et al. Dual therapy with clarithromycin and omeprazole for the treatment of active duodenal ulcers. Am J Gastroenterol 1994;89:1389.
44. Bazzoli F, Zagari RM, Fossi P, Pozzato P, Roda A, Roda E. Short-term low-dose triple therapy for eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1994;6:773-777.
45. Labenz J, Stolte M, Rühl G, Becker T, Tillenburg B, Sollböhmer M, Börsch G. One-week low-dose triple therapy for the eradication of Helicobacter pylori infection. Eur J Gastroenterol 1995;7:9-11.
46. Yousfi MM, El-Zimaity HMT, Al-Assi MT, Cole RA, Genta RM, Graham DY. Metronidazole, omeprazole and clarithromycin; an effective combination for Helicobacter pylori infection. Aliment Pharmacol Ther 1995;9:209-212.
47. Jaup BH, Norrby A. Low-dose, short-term triple therapy for cure of Helicobacter pylori infection and healing of peptic ulcers. Am J Gastroenterol 1995;90:943-945.
48. Moyyaedi P, Sabay P, Tompkins DS, Axon ATR. Efficacy and optimum dose of omeprazole in a new 1-week triple therapy regimen to eradicate Helicobacter pylori. Eur J Gastroenterol 1995;7:835-840.
49. Labenz J, Börsch G. Toward an optimal treatment for Helicobacter pylori-positive peptic ulcers. Am J Gastroenterol 1995;90:692-694.
50. Hentschel E, Brandstätter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcers. N Engl J Med 1993;328:308-312.
51. Yousfi MM, El-Zimaity HMT. Cole RA, Genta RM, Graham DY. Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy). Aliment Pharmacol Ther 1996;10:119-123.
52. Lind T, Veldhuyzen van Zanten SJO, Unge P, Spiller RC, Bayerdörffer E, O'Morain C, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: The MACH-1 Study. Helicobacter 1996;1:138-144.
53. Jaup B, Norrby A. Comparison of two low-dose one-week triple therapy regimens with and without metronidazole for cure of Helicobacter pylori infection. Gastroenterology 1995;108:A123.
54. Labenz J, Peitz U, Tillenburg B, et al. Kurzzeit-Tripel-therapie mit Pantoprazol, Clarithromycin und Metronidazol zur Eradikation von Helicobacter pylori. Leber Magen Darm 1995;25:122-127.
55. Graham DY, de Boer WA, Tytgat GNJ. Choosing the best anti-Helicobacter pylori therapy. Effect of antimicrobial resistance. Am J Gastroenterol 1996;91:1072-1076.
56. van der Hulst RWM, Keller JJ; Rauws EAJ, Tytgat GNJ. Treatment of Helicobacter pylori infection; a review of the world literature. Helicobacter 1996;1:6-9.
57. Unge P. Review of Helicobacter pylori eradication regimens. Scand J Gastroenterol 1996;31(suppl 215):74-81.
58. Bardhan KD, Graham DY. Hunt RM, O'Morain. Effects of smoking on cure of Helicobacter pylori infection and duodenal ulcer recurrence in patients treated with clarithromycin and omeprazole. Helicobacter 1997, in press.
59. Labenz J, Leverkus F, B̈orsch G. Omeprazole plus amoxicillin for cure of Helicobacter pylori infection: factors influencing the treatment success. Scand J Gastroenterol 1994;29:1070-1075.
60. Hawkey CJ. Non-steroidal anti-inflammatory drugs and peptic ulcers. Br Med J 1990;300:278-284.
61. Langmann MJS, Weil J, Wainwright P, Lawson DH, et al. Risks of bleeding ulcers associated with individual non-steroidal anti-inflammatory drugs. Lancet 1994;343:1075-1078.
62. Ng TM, Fock KM, Khor JL, Teo EK, Chia SC. Helicobacter pylori and NSAIDs in bleeding gastric ulcer. Gut 1996;39(suppl 2):A26.
63. Kohl H, Leverkus F, Labenz J. H. pylori infection increases the risk of peptic ulcer bleeding - a case control study. Gut 1996;39(suppl 2):A26.
64. Lee YT, Chan FKL, Sung JY, Leung VKS, To KF, Yung MY, et al. Prevention of NSAID-induced ulcer by eradication of H. pylori. A prospective randomized study. Gut 1996;39(suppl 2):A26.
65. Graham DY, Hepps KS, Ramirez FC, Lew GM, Saeed ZA. Treatment of Helicobacter pylori reduces the rate of rebleeding in peptic ulcer disease. Scand J Gastroenterol 1993;28:939-942.
66. Labenz J, Börsch G. Role of Helicobacter pylori eradication in the prevention of peptic ulcer bleeding relapse. Digestion 1994;55:27-33.
67. Rokkas T, Karameris A, Mavrogeorgis A, Rallis E, Giannikos N. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995:41:1-4.
68. Jaspersen D, Koerner T, Schorr W, Hammar CH. Helicobacter pylori eradication prevents relapse bleeding in duodenal ulcer hemorrhage. Endoscopy 1994;26:85.
69. Maier M, Schilling D, Dorlars D, Wegener K, Kohler B, Benz C, Riemann JF. Eradication of Helicobacter pylori or H2 blocker maintenance therapy after peptic ulcer bleeding - a prospective randomized trial. Gastroenterology 1995;108:A156.
70. Santander C, Gravalos RG, Gomez-Cedenilla A, Cantero J, Pajares JM. Antimicrobial therapy for Helicobacter pylori infection versus long-term maintenance antisecretion therapy in the prevention of recurrent hemorrhage from peptic ulcer:prospective non-randomized trial on 125 patients. Am J Gastroenterol 1996;91:1549-1552.
71. Graham DY, Genta RM. Reinfection with H. pylori. In: Hunt RH and Tytgat GNJ (eds) Helicobacter pylori. Basic mechanisms to clinical cure. Kluwer, Dordrecht, 1994;113-120.
72. McCarthy C, Patchett S, Collins RM, et al. Long-term prospective study of Helicobacter pylori in non-ulcer dyspepsia. Dig Dis Sci 1995;40:114-119.
73. Xia HX, Windle HJ, Marshall DG, et al. Recrudescence of Helicobacter pylori infection after apparently successful eradication: novel application of randomly amplified polymorphic DNA fingerprinting. Gut 1995;37:30-34.
74. Borody, TJ, Andrews P, Mancuso N, et al. Helicobacter pylori reinfection rate in patients with cured duodenal ulcer. Am J Gastroenterol 1994;89:529-532.
75. Forbes GM, Glaser ME, Cullen DJE, et al. Duodenal ulcer treated with Helicobacter pylori eradication: seven-year followup. Lancet 1994;343:258-260.
76. Miehlke S, Bayerdörffer E, Lehn N, Meining A, Bästlein E, Mannes GA, Stolte M. Helicobacter pylori reinfection is rare in peptic ulcer patients cured by antimicrobial therapy. Eur J Gastroenterol 1996;8:1-3.
77. Wilhelmsen I, Berstad A. Quality of life and relapse of duodenal ulcers before and after eradication of Helicobacter pylori. Scand J Gastroenterol 1994;29:874-9.
78. Cutler AF, Schubert T. Long-term Helicobacter pylori recurrence after successful eradication with triple therapy. Am J Gastroenterol 1993;88:1359-6.
79. Figueroa G, Acuna R, Troncoso M, Portell DP, Toledo MS, Albornoz V, Vigneaux J. Low Helicobacter pylori reinfection rate after triple therapy in Chilean duodenal ulcer patients. Am J Gastroenterol 1996;91:1395-1399.
80. Louw JA, Lucke W, Jaskiewicz K, Lastovica AJ, Winter TA, Marks IN. Helicobacter pylori eradication in the African setting, with special reference to reinfection and duodenal ulcer recurrence. Gut 1995;26:544-547.
81. Oderda G, Vaira D, Ainley C, Holton J, Osborn J, Altare F, Ansaldi N. Eighteen months follow up of Helicobacter pylori positive children treated with amoxicillin and tinidazole. Gut 1992;33:1328-1330.
82. Coelho LG, Passos MC, Chausson Y, Costa L, Maia AF, Brandao MJ, Rodriguez DC, Castro LP. Duodenal ulcer and eradication of Helicobacter pylori in a developing country. An 18-month follow-up study. Scand J Gastroenterol 1992;27:362-366.
83. Coelho LG, Passos MC, Chausson Y, Castro FJ, Vieira WLS, Franco JMM, et al. Factors involved in reinfection by H. pylori in Brazil. Gut 1996;39(suppl 2):abstract.
84. Enroth H, Engstrand L. Immunomagnetic separation and PCR for detection of Helicobacter pylori in water and stool specimens. J Clin Microbiol 1995;33:2162-2165.
85. Klein PD, Graham DY, Gaillow A, Opekun AR, O'Brian Smith E. Water source as a risk factor for Helicobacter pylori infection in Peruvian children. Lancet 1991;337:1503-1506.
86. Drumm B, Perez-Perez GI, Blaser MJ, Sherman PM. Intrafamiliar clustering of Helicobacter pylori infection. N Engl J Med 1990;322:359-363.
87. Malaty HM, Graham DY, Klein PD, Evans DG; Adam E, Evans DJ. Transmission of Helicobacter pylori infection: studies in families of healthy individuals. Scand J Gastroenterol 1991:26:927-932.
88. Schütze K, Hentschel E, Dragosics B, Hirschl AM. Helicobacter pylori reinfection with identical organisms: transmission by the patients spouses. Gut 1995;36:831-833.
89. Graham DY, Malaty HM, Go MF. Are there susceptible host to Helicobacter pylori infection? Scand J Gastroenterol 1994;205:6-10.
90. Malaty HM, Engstrand L, Pederson N, Graham DY. Helicobacter pylori infection: genetic and environmental influences. A study on twins. Ann Intern Med 1994;120:982-986.
91. El-Zimaity HMT, Al-Assi MT, Genta RM, Graham DY. Confirmation of successful therapy of Helicobacter pylori infection: number and sites of biopsies or a rapid urease test. Am J Gastroenterol 1995;90:1962-1964.